Patents by Inventor Matthew Roberts Nelson

Matthew Roberts Nelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for Drug-Induced Liver Injury
    Publication number: 20100035265
    Abstract: The present invention provides a method for predicting the risk of a patient for developing adverse drug reactions, particularly Drug-Induced Liver Injury (DILI) or hepatotoxicity. The invention also provides a method of identifying a subject afflicted with, or at risk of, developing DILI. In some aspects, the methods comprise analyzing at least one genetic marker, wherein the presence of the at least one genetic marker indicates that the subject is afflicted with, or at risk of, developing DILI.
    Type: Application
    Filed: July 17, 2009
    Publication date: February 11, 2010
    Inventors: Aris FLORATOS, Sally L. JOHN, Matthew Roberts NELSON, Ann K. DALY
  • METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
    Publication number: 20090317816
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: March 9, 2009
    Publication date: December 24, 2009
    Applicant: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland
  • Methods for Identifying Risk of Breast Cancer and Treatments Thereof
    Publication number: 20090305284
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 10, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard R. Roth, Andreas Braun, Stefan M. Kammerer, Matthew Roberts Nelson, Rikard Henry Reneland, Carolyn R. Hoyal-Wrightson
  • METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
    Publication number: 20090258344
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: October 15, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Andreas Braun, Stefan M. Kammerer, Mikhail F. Denissenko, Rikard Reneland, Caridad Rosette, Carolyn R. Hoyal-Wrightson
  • Methods for identifying risk of breast cancer and treatments thereof
    Patent number: 7510835
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: March 31, 2009
    Assignee: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland